Vancomycin powder doesn't cut infection post-spine surgery

December 10, 2013
Vancomycin powder doesn't cut infection post-spine surgery

(HealthDay)—For patients undergoing spinal procedures, the local application of vancomycin powder in surgical wounds does not significantly reduce the incidence of infection, according to a study published in the Dec. 1 issue of Spine.

Vijay Ramappa Tubaki, from Ganga Hospital in Coimbatore, India, and colleagues randomized 907 patients with various spinal pathologies who were treated surgically during a period of 18 months to receive either standard systemic prophylaxis only (controls) or vancomycin powder in the surgical wound plus systemic prophylaxis (treatment group). Infection incidence was evaluated as the primary outcome.

The researchers found that the incidence of infections was 1.68 percent in the (six deep and two superficial), compared with 1.61 percent in the treatment group (six deep and one superficial). Bacteria were cultured in three cases in each group, with one case of Escherichia coli and two of Staphylococcus aureus in the control group and one case of Staphylococcus aureus and two of Klebsiella in the treatment group. The use of vancomycin powder was not associated with any adverse effects. The infection rate did not differ significantly between the groups.

"The use of powder may not be effective when incidence of infection is low," the authors conclude.

Explore further: Instrumented spinal fusion method impacts infection rate

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Instrumented spinal fusion method impacts infection rate

May 21, 2012

(HealthDay) -- For patients who undergo instrumented spinal fusion, the rates of infection are higher among those who receive posterior lumbar interbody fusion compared with those who receive posterior or posterolateral fusion, ...

Less commonly prescribed antibiotic may be better

August 16, 2012

The antibiotic most commonly prescribed to treat bloodstream infections in dialysis patients may not always be the best choice, according to a study appearing in an upcoming issue of the Journal of the American Society of ...

Vibativ approved for certain bacterial pneumonia

June 24, 2013

(HealthDay)—The antibiotic Vibativ (telavancin) has been approved by the U.S. Food and Drug Administration to treat pneumonia caused by Staphylococcus aureus bacteria when other treatments aren't suitable.

Local vancomycin reduces infections in cervical fusion

June 24, 2013

(HealthDay)—The local application of prophylactic vancomycin significantly reduces the risk of surgical site infections in patients undergoing multilevel posterior cervical-instrumented fusions for cervical spondylotic ...

Modifiable factors ID'd for reducing surgical site infections

September 30, 2013

(HealthDay)—Specific modifiable preoperative, intraoperative, and postoperative factors can be optimized to reduce the risk of surgical site infections (SSIs) for patients undergoing elective orthopedic surgery, according ...

Pediatric musculoskeletal MRSA infections on the rise

October 26, 2013

Pediatric musculoskeletal Staphylococcus aureus bacterial infections have been evolving over the past decade, with more children diagnosed with the more virulent, methicillin-resistant Staphylococcus aureus (MRSA) today than ...

Recommended for you

Ebola virus mutations may help it evade drug treatment

September 11, 2015

Genetic mutations called "escape variants" in the deadly Ebola virus appear to block the ability of antibody-based treatments to ward off infection, according to a team of U.S. Army scientists and collaborators. Their findings, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.